US11186564B2ActiveUtilityA1

Dual NAV1.2/5HT2a inhibitors for treating CNS disorders

41
Assignee: SUNOVION PHARMACEUTICALS INCPriority: Aug 4, 2016Filed: Aug 4, 2016Granted: Nov 30, 2021
Est. expiryAug 4, 2036(~10.1 yrs left)· nominal 20-yr term from priority
C07D 211/42C07D 311/58C07D 221/20C07D 249/12C07D 213/81C07D 295/104C07D 207/36C07D 403/06C07D 295/088A61P 25/18C07D 491/20C07D 417/04C07D 513/04C07D 405/12A61P 25/28C07D 413/08C07D 401/14C07D 471/10C07D 211/44C07D 207/12C07D 487/10C07D 491/107C07D 471/08C07D 491/048C07D 401/12C07D 217/24C07D 235/12C07D 311/08C07D 413/06C07D 277/66C07D 401/08C07D 307/83C07D 401/06C07D 265/30C07D 211/58C07D 223/08C07D 295/027C07D 295/073C07D 241/04C07D 405/06C07D 267/10C07D 243/08C07D 295/096C07D 295/108C07D 275/04C07D 471/04C07D 311/22C07D 237/14
41
PatentIndex Score
0
Cited by
16
References
11
Claims

Abstract

Compounds of formula I:are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disorders in a patient in need are also disclosed. Such disorders include depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, autism, a cognitive impairment, or a neuropsychiatric symptom such as apathy, depression, anxiety, psychosis, aggression, agitation, impulse control disorders, and sleep disorders in neurological disorders such as Alzheimer's and Parkinson's diseases.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A compound of formula I 
       
         
           
           
               
               
           
         
       
       wherein
 Q is piperidine attached to L 1  at a nitrogen, wherein substituents, when present, are selected from the group consisting of halogen, hydroxy, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, and oxo; 
 R A  is selected from the group consisting of (1) an optionally substituted bicyclic carbocycle containing an aromatic 6-membered ring and a non-aromatic 5-membered ring; and (2) an optionally substituted, bicyclic heterocycle selected from the group consisting of a cyclopenta[b]pyridine, a dihydrobenzofuran, a dihydrofuro[3,2-b]pyridine, a cyclopenta[c]pyridine, an indoline, a pyrrolo[3,4-b]pyridine, and an isoindoline; 
 L 1  is —(CH 2 CHR 1 )—, wherein R 1  is hydrogen or methyl; 
 L 2  is —O—; and 
 R B  is an optionally substituted aromatic carbocycle wherein substituents, when present, are selected from the group consisting of halogen, cyano, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )oxaalkyl, —C(═O)NH 2 , and di(C 1 -C 6 )alkylamino. 
 
     
     
       2. A compound according to  claim 1  wherein R A  is an optionally substituted bicyclic carbocycle containing an aromatic 6-membered ring and a non-aromatic 5-membered ring. 
     
     
       3. A compound according to  claim 1  wherein R A  is an optionally substituted bicyclic heterocycle selected from the group consisting of a cyclopenta[b]pyridine, a dihydrobenzofuran, a dihydrofuro[3,2-b]pyridine, a cyclopenta[c]pyridine, an indoline, a pyrrolo[3,4-b]pyridine, and an isoindoline. 
     
     
       4. A compound according to  claim 1  wherein L 1  is —CH 2 CH 2 —. 
     
     
       5. A compound according to  claim 1  wherein R A  is selected from the group consisting of indane, dihydrobenzofuran, 3-methyldihydrobenzofuran, methylindane, haloindane, cyanoindane, and methoxyindane. 
     
     
       6. A compound according to  claim 1  wherein R B  is selected from the group consisting of benzene, halobenzene, methylbenzene, dimethylbenzene, and methoxybenzene. 
     
     
       7. A compound according to  claim 1  wherein the piperidine Q is unsubstituted or is substituted with one or two methyls. 
     
     
       8. A compound according to  claim 1  wherein R A  is indane. 
     
     
       9. A compound according to  claim 1  wherein R B  is halobenzene. 
     
     
       10. A compound according to  claim 1  wherein R B  is dimethylbenzene. 
     
     
       11. A compound according to  claim 1  selected from the group consisting of: 
       
         
           
                 
                 
               
                     
                 
                   171 
                   
                     
                       
                       
                           
                           
                       
                     
                   
                 
                     
                 
                   172 
                   
                     
                       
                       
                           
                           
                       
                     
                   
                 
                     
                 
                   173 
                   
                     
                       
                       
                           
                           
                       
                     
                   
                 
                     
                 
                   174 
                   
                     
                       
                       
                           
                           
                       
                     
                   
                 
                     
                 
                   175 
                   
                     
                       
                       
                           
                           
                       
                     
                   
                 
                     
                 
                   176 
                   
                     
                       
                       
                           
                           
                       
                     
                   
                 
                     
                 
                   177 
                   
                     
                       
                       
                           
                           
                       
                     
                   
                 
                     
                 
                   178 
                   
                     
                       
                       
                           
                           
                       
                     
                   
                 
                     
                 
                   185 
                   
                     
                       
                       
                           
                           
                       
                     
                   
                 
                     
                 
                   186 
                   
                     
                       
                       
                           
                           
                       
                     
                   
                 
                     
                 
                   187 
                   
                     
                       
                       
                           
                           
                       
                     
                   
                 
                     
                 
                   188 
                   
                     
                       
                       
                           
                           
                       
                     
                   
                 
                     
                 
                   189

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.